Proteomics has become the spotlight for pharmaceutical and biotechnology companies, offering new avenues to precision medication and customized diagnosis and treatment. In the post genomic era, proteomics technologies are expected to play a crucial part in the fields of medicine, molecular diagnostics, and drug discovery. Some of the most commonly employed technologies include protein analysis by mass spectrometry and 2D gel electrophoresis for separation of proteins. In the field of medicine, proteomics are expected to benefit from the personalization of medicine as well as from the combination of diagnostics and therapeutics.
In the overall proteomic technologies market, protein biochip and bioinformatics technologies are expected to witness the maximum expansion and development, while neurological disorders and cancer are likely to emerge as the key application areas.